Share Name Share Symbol Market Type Share ISIN Share Description
Clinigen Group Plc LSE:CLIN London Ordinary Share GB00B89J2419 ORD 0.1P
  Price Change % Change Share Price Shares Traded Last Trade
  12.00 1.46% 832.50 403,396 16:35:19
Bid Price Offer Price High Price Low Price Open Price
830.00 830.50 832.00 814.50 830.50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 504.30 22.60 10.30 80.8 1,106
Last Trade Time Trade Type Trade Size Trade Price Currency
17:29:14 O 347 830.032 GBX

Clinigen (CLIN) Latest News

More Clinigen News
Clinigen Investors    Clinigen Takeover Rumours

Clinigen (CLIN) Discussions and Chat

Clinigen Forums and Chat

Date Time Title Posts
24/2/202122:59Clinigen - Speciality Pharmaceuticals1,052
24/9/202022:34Clinigen - solid looking growth stock108

Add a New Thread

Clinigen (CLIN) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Clinigen trades in real-time

Clinigen (CLIN) Top Chat Posts

Clinigen Daily Update: Clinigen Group Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker CLIN. The last closing price for Clinigen was 820.50p.
Clinigen Group Plc has a 4 week average price of 700p and a 12 week average price of 662p.
The 1 year high share price is 940p while the 1 year low share price is currently 515p.
There are currently 132,898,771 shares in issue and the average daily traded volume is 454,845 shares. The market capitalisation of Clinigen Group Plc is £1,106,382,268.58.
adamb1978: Yes, I think the share price is factoring in that level of debt being permanent and the company not managing to reduce it this calendar year to the 1x-2x range which they've been talking about for a while now.
adamb1978: Hi Cellars Yes, I had a look through the results this morning, but need a closer look later. Gut feel was that they were what I was expecting with a slight positive comment about current year growth Market forecasts are for 63p EPS this year growing to 87p in FY23 and I think those figures are very achievable. On that basis, I think £10-£12 share price is eminently achievable within a couple years. The de-gearing over the course of this year I think will help move the share price along, along with the general achievement of results. Adam
whatja: There have been regular 3% and more gains recently as it has gone from 700 to 800 The trading update was useful but there has been limited news to drive the price. Next formal update will be HY reporting in March.
thewheeliedealer: Hi all, My mate Peter @Conkers3 and myself did a ‘Twin Petes Investing’ Podcast a few days ago and part of our discussion includes CLIN (which I hold myself) and some others with a similar business model. We also chatted about loads of other Stocks and Ideas for research and a fair bit of educational stuff with regards to Investing and Portfolio Management. Anyway, if you use Youtube, Apple, Audioboom, Overcast or Spotify you can find it under the 'Conkers Corner' Channel (you want Podcast TPI 39) and you can find it on Soundcloud at the link below. I hope you enjoy it and find it useful, we try to keep them light and they are totally unscripted, not like all the stuffy financial fodder you are probably more used to !! Happy New Lockdown !! WD @wheeliedealer hTTps://
energeticbacker: The greatest concern, according to Investor's Champion, surrounds any potential impact from the launch of a Foscavir generic in the EU, which has no doubt been weighing on the price over recent months. The shares actually haven’t gone anywhere for 5 years which probably has something to do with the ‘real’ declining returns on equity.
adamb1978: I dont think so (or certainly hope not!). The share price is just lacking near-term impetus but once we get into 2021 and leverage comes off and they start to trend to their stated growth targets I think you'll see the share price recover. I'm still looking for £12 within a couple years
adorling: When does CLIN go ex-dividend?
bennya: Share price drifted recently, hoping for a good set of results tomorrow to get this back on track. GLA
fernagx: I do think that 11% is a bit of an overreaction. Covid-19 should have already been built into the share price and the Directors have been clear on the trading conditions expected that lie ahead. It will be better to wait until we get full results. If things continue as they are and Covid 19 eases somewhat I expect a return to £8/share. They really need to focus on reducing their debt. Gearing is high.
adamb1978: Solid trading statement this morning which underpins the investment case in my view. Decent top-line and profit growth and re-iterating their intention to take leverage down over the next 12-18 months via organic means. Still believe that these are very cheap. Historically they've traded on a 15x-20x PE and based on EPS in 65p-70 range today growing to the 90s over 2-3 years, I dont think its unreasonable to expect the share price to be able to get to the £15 area in that time-frame. Very happy continuing to hold
Clinigen share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210412 01:18:46